Korean Pharma and Biotech Exports Top 13 Trillion Won in H1

Korean pharmaceutical and biotech firms reported record export earnings. Their global technology exports exceeded 13 trillion won in the first half of the year. The figure reflects combined sales of medicines, vaccines and related technologies. Growth was driven by strong demand in overseas markets. The surge underscores South Korea's expanding role in the health sector. Industry analysts see the trend continuing into the second half. Export performance may boost the country's trade balance. Observers will watch upcoming policy measures to sustain momentum.